1-(4-(4-chlorophenylsulfonyl)phenyl)-3-(pyridin-4-ylmethyl)urea

ID: ALA4871017

PubChem CID: 135222553

Max Phase: Preclinical

Molecular Formula: C19H16ClN3O3S

Molecular Weight: 401.88

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccncc1)Nc1ccc(S(=O)(=O)c2ccc(Cl)cc2)cc1

Standard InChI:  InChI=1S/C19H16ClN3O3S/c20-15-1-5-17(6-2-15)27(25,26)18-7-3-16(4-8-18)23-19(24)22-13-14-9-11-21-12-10-14/h1-12H,13H2,(H2,22,23,24)

Standard InChI Key:  LRFUAJAYJSNHRR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   41.7717  -13.0503    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.1844  -13.7602    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   42.5928  -13.0478    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.5350  -15.4157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2412  -15.0044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9504  -15.4104    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.6566  -14.9991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3658  -15.4050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.0720  -14.9938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6535  -14.1819    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.7773  -15.4014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4829  -14.9909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.4803  -14.1728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7661  -13.7671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0633  -14.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8271  -15.0064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1214  -15.4170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1240  -16.2350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.8382  -16.6408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5410  -16.2279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8902  -14.1688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8864  -14.9853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.5914  -15.3939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.2991  -14.9869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.2974  -14.1672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.5919  -13.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.0068  -15.3954    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15  9  1  0
 13  2  1  0
  4 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  4  1  0
  2 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 24 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4871017

    ---

Associated Targets(Human)

NAMPT Tchem Nicotinamide phosphoribosyltransferase (3221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.88Molecular Weight (Monoisotopic): 401.0601AlogP: 3.89#Rotatable Bonds: 5
Polar Surface Area: 88.16Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.68CX Basic pKa: 5.02CX LogP: 3.17CX LogD: 3.17
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: -1.78

References

1. Pinkerton AB, Sessions EH, Hershberger P, Maloney PR, Peddibhotla S, Hopf M, Sergienko E, Ma CT, Smith LH, Jackson MR, Tanaka J, Tsuji T, Akiu M, Cohen SE, Nakamura T, Gardell SJ..  (2021)  Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators.,  41  [PMID:33798699] [10.1016/j.bmcl.2021.128007]

Source